Related Experiment Video
Updated: May 2, 2026

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
Published on: October 3, 2011
[Cerebrolysin in pediatric neurology practice]
1Kafedra nevrologii, neĭrokhirurgii i meditsinskoĭ genetiki lechebnogo fakul'teta GBOU VPO "Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova", Moskva.
Cerebrolysin treatment shows high efficacy and good tolerability for various pediatric nervous system disorders. This therapy offers expanded options for children
Area of Science:
- Pediatric Neurology
- Neuroscience
- Pharmacology
Context:
- Nervous system disorders in children represent a significant clinical challenge.
- Current therapeutic options for pediatric neurological conditions are diverse but require effective treatments.
- Cerebrolysin, a complex mixture of peptides, has been investigated for neuroprotective and neurotrophic effects.
Purpose:
- To describe the various aspects of Cerebrolysin treatment in pediatric patients.
- To evaluate the efficacy and tolerability of Cerebrolysin for a broad spectrum of nervous system disorders in children.
- To assess the potential of Cerebrolysin in enhancing therapeutic outcomes in pediatric neurology.
Summary:
- The study details the application of Cerebrolysin across a wide array of nervous system disorders in pediatric populations.
- Results indicate that Cerebrolysin therapy is highly effective and demonstrates excellent tolerability.
- Observed benefits suggest Cerebrolysin is a valuable therapeutic agent for children with neurological conditions.
Impact:
- The findings broaden the therapeutic perspectives for Cerebrolysin utilization within pediatric neurology.
- Establishes Cerebrolysin as a promising treatment option, potentially improving patient outcomes.
- Encourages further research into Cerebrolysin's mechanisms and applications in pediatric neurological care.
More Related Videos
10:24Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods
Published on: November 19, 2019
06:19Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Cerebrospinal Fluid
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
Cerebral Edema l: Introduction